Healthcare & Life Sciences
Cognition Therapeutics
United Statescognitiontherapeutics.com
Cognition Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series B, 1 tracked investor.
series-b
series-b
Stage
1
Investors
About Cognition Therapeutics
Cognition Therapeutics is a company headquartered in the United States. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Cognition Therapeutics develops drug candidates that target the underlying mechanisms of neurodegenerative diseases such as Alzheimer's disease.
Explore Cognition Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.